Ribonucleotide reductases catalyze the formation of deoxyribonucleotides by the reduction of the corresponding ribonucleotides. Eukaryotic ribonucleotide reductases are ␣ 2 ␤ 2 tetramers; each of the larger, ␣ subunits possesses binding sites for substrate and allosteric effectors, and each of the smaller, ␤ subunits contains a binuclear iron complex. The iron complex interacts with a specific tyrosine residue to form a tyrosyl free radical which is essential for activity. Previous work has identified two genes in the yeast Saccharomyces cerevisiae, RNR1 and RNR3, that encode ␣ subunits and one gene, RNR2, that encodes a ␤ subunit. Here we report the identification of a second gene from this yeast, RNR4, that encodes a protein with significant similarity to the ␤-subunit proteins. The phenotype of rnr4 mutants is consistent with that expected for a defect in ribonucleotide reductase; rnr4 mutants are supersensitive to the ribonucleotide reductase inhibitor hydroxyurea and display an S-phase arrest at their restrictive temperature. rnr4 mutant extracts are deficient in ribonucleotide reductase activity, and this deficiency can be remedied by the addition of exogenous Rnr4p. As is the case for the other RNR genes, RNR4 is induced by agents that damage DNA. However, Rnr4p lacks a number of sequence elements thought to be essential for iron binding, and mutation of the critical tyrosine residue does not affect Rnr4p function. These results suggest that Rnr4p is catalytically inactive but, nonetheless, does play a role in the ribonucleotide reductase complex.
Ribonucleotide reductases catalyze the formation of deoxyribonucleotides by the reduction of the corresponding ribonucleotides. Three classes of ribonucleotide reductases have been well characterized (24) . Class I enzymes are found in all eukaryotes and some prokaryotes. The best-studied class I enzyme is the Escherichia coli ribonucleotide reductase (10, 30) , an ␣ 2 ␤ 2 tetramer that can be decomposed to two catalytically inactive homodimers, R1 (␣ 2 ) and R2 (␤ 2 ). Each of the larger ␣ subunits possesses binding sites for substrate and allosteric effectors and also contains several redox-active cysteine residues. Each of the smaller ␤ subunits contains a binuclear Fe(III) complex. The X-ray structure of E. coli R2 reveals that the iron ions are bridged by both an O 2Ϫ ion and the carboxyl group of a glutamate residue (22) . Each iron is further liganded by two carboxyl oxygen atoms from aspartate or glutamate residues, a histidine N␦ residue, and a water molecule. The recently solved structure of the mouse R2 protein indicates that the iron-binding center of eukaryotic proteins is similar to that of the E. coli protein (17) . The iron complex interacts with a specific tyrosine residue to form a tyrosyl free radical which is essential for activity. The enzyme is inhibited by hydroxyurea, which specifically quenches the tyrosyl radical (19) .
Amino acid sequence alignments of the class 1 R2 proteins from different species identify 16 residues that are conserved in all of these proteins reported to date (7, 22) . Most of these conserved residues are at the iron center or close to it.
Previous work has identified two genes in the yeast Saccharomyces cerevisiae (RNR1 and RNR3) that encode R1 proteins (8) and one gene (RNR2) that encodes an R2 protein (7, 13) .
Here we report the identification of a second gene from this yeast, RNR4, that encodes a protein with significant similarity to the R2 proteins. However, Rnr4p lacks a number of sequence elements thought to be essential for enzymatic function. Our evidence suggests that Rnr4p is catalytically inactive but, nonetheless, does play a role in the ribonucleotide reductase complex.
MATERIALS AND METHODS
Yeast strains and media. The yeast strains used for these experiments are listed in Table 1 . A yeast strain containing the qcr9-⌬1 mutation was obtained from B. Trumpower (Dartmouth College, Hanover, N.H.) and backcrossed to CUY8 to obtain CUY977. A yeast strain containing the rnr2-68 mutation was obtained from S. Elledge (Baylor College of Medicine, Houston, Tex.) and backcrossed to CUY8 to obtain CUY989 and CUY990. DL2 and DL2rho 0 were obtained from T. Fox (Cornell University, Ithaca, N.Y.).
Yeast extract-peptone-dextrose (YPD), yeast extract-peptone-glycerol (YPG), and synthetic minimal (SD) media and plates were prepared as described by Sherman (28) . Sporulation medium was 0.3% potassium acetate. Plates containing hydroxyurea or benomyl were made by adding the indicated amount of these drugs to YPD agar after autoclaving.
Cloning and disruption of RNR4. The RNR4 gene was cloned by complementation of the rnr4-1 cold-sensitive phenotype. CUY58 was transformed with a yeast genomic library constructed in the URA3 YCp50 vector (26) . Following transformation, cells were plated on SD lacking uracil, grown at 30°C for 16 h, and then shifted to 14°C. One Ura ϩ transformant which grew at 14°C was isolated. The plasmid recovered from this strain, pRC1, was able to complement the cold-sensitive phenotype of rnr4-1 following retransformation back into CUY58.
The RNR4 gene was disrupted by the one-step gene replacement method (27) . The 3-kb XbaI-BamHI fragment of pRC1 was subcloned into the SpeI-BclI sites of pCR2.1 (Invitrogen Corp., Carlsbad, Calif.). The 950-bp BglII-EcoRI fragment was then replaced with a 3-kb BamHI-EcoRI fragment containing the HIS3 gene to create pWP77. This construct deletes RNR4 sequences extending from 50 bp upstream of the start codon to codon 302. The 4.2-kb SpeI-SpeI fragment of pWP77 was gel purified and transformed into the diploid strain CUY546. Two transformants were isolated. Southern blotting and PCR confirmed that in each case one copy of RNR4 was disrupted by HIS3 (data not shown). Sporulation and tetrad dissection were used to obtain haploid cells containing the disruption (rnr4-⌬1). rnr4-⌬1 cells from the two transformants behaved similarly.
Plasmid constructs. The 2.5-kb KpnI-BamHI fragment of pRC1 (see Fig. 1 ) was subcloned into pRS416 (29) to create pRC2, a YCp plasmid containing RNR4. The 2.5-kb KpnI-BamHI fragment of pRC1 was also subcloned into pRS426 (4) to create pRC4, a YEp plasmid containing RNR4. pSE327, a YEp plasmid containing RNR2, was obtained from S. Elledge (Baylor College of Medicine).
The rnr4-2 allele was constructed by oligonucleotide-directed mutagenesis by the overlapping PCR method as described by Eichinger et al. (6) . Four oligonucleotide primers were used; primer A (AAAAATTGCTAATACAAA AACA), primer B (AACCATCATGGAGAAAACTTCAGAG), primer C (CT CTGAAGTTTTCTCCATG), and primer D (AGCGGTAGCGACATCCT CCAT). Primers A and D are the outer primers. Primers B and C are the internal primers; these primers are complementary to each other and both contain the point mutation (underlined) that changes codon 131 of RNR4 from TAC, encoding tyrosine, to TTC, encoding phenylalanine. Two separate PCRs with pRC2 as template DNA were performed with primers A and B and with primers C and D, respectively. The products of these reactions were mixed and subjected to another round of PCR with primers A and D. The BglII-EcoRI fragment of the final PCR product was used to replace the BglII-EcoRI fragment of pRC2, creating pWP155, a YCp plasmid containing the rnr4-2 allele. DNA sequencing confirmed that the desired mutation had been created.
Immunofluorescence microscopy. Cells were prepared for immunofluorescence microscopy as described previously (23) . Rabbit anti-␤-tubulin polyclonal antibody 206 (1) was a gift from F. Solomon (Massachusetts Institute of Technology, Cambridge, Mass.). Fluorescein-conjugated goat antirabbit antibodies were obtained from Cappel Research Products (Durham, N.C.). Cellular DNA was visualized by staining with 4Ј,6Ј-diamidino-2-phenylindole (DAPI).
Flow cytometry. Diploid yeast cells were prepared for flow cytometry by the method of Hutter and Eipel (15) . The RNR4 diploid strain was made by mating CUY25 and CUY26. The rnr4-⌬1 diploid strain was made by mating CUY995 and CUY996.
Measurement of induction of RNR4. Hydroxyurea or methyl methanesulfonate (MMS) was added to log-phase cultures of CUY26 cells at a final concentration of 0.1 M or 0.017%, respectively. Aliquots of 7.5 ϫ 10 7 cells were collected at 0, 2, and 4 h after addition of drug. Cells were spheroplasted by treatment with 375 g of Zymolyase (100T) per ml in 1.2 M sorbitol-0.1 M potassium phosphate (pH 7.5) at 30°C for 15 min. Spheroplasted cells were lysed by gentle vortexing in 0.5 ml of 4.3 M guanidinium thiocyanate. Total RNA was extracted by the one-step method (3). RNA was reconstituted in water treated with diethyl pyrocarbonate and quantified by spectrophotometry.
Three micrograms of RNA per lane was electrophoresed in a 1.4% formaldehyde agarose gel in morpholinepropanesulfonic acid buffer. RNA was then transferred to a GeneScreen membrane in 20ϫ SSC (1ϫ SSC is 15 mM sodium citrate plus 150 mM sodium chloride) and cross-linked to the membrane by baking at 80 to 100°C for 2 h. Hybridization probes for RNR4 and ACT1 were prepared by random priming with [␣-32 P]dCTP. The blots were prehybridized for 4 h at 42°C in hybridization buffer containing 5ϫ SSC, 5ϫ Denhardt solution, 50% formamide, and 100 g of single-stranded DNA per ml. Probes were added, and hybridization was carried out overnight. The blots were washed in 1.5ϫ SSC-0.1% sodium dodecyl sulfate for 10 min at room temperature and then in 0.15ϫ SSC-0.1% sodium dodecyl sulfate at 42°C for 20 min. mRNA levels were measured with a Fuji PhosphoImager. The amount of RNR4 mRNA in each lane was normalized to the amount of ACT1 mRNA in the same lane.
Measurement of ribonucleotide reductase activity in yeast extracts. Yeast extracts from strains CUY26 and CUY995 were prepared as described by Vitols et al. (33) with the following modifications. Logarithmically growing yeast cells were cooled rapidly to 0°C, harvested, washed, and suspended in an equal volume of lysis buffer containing 0.05 M Tris-HCl (pH 7.5), 2 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 2 M pepstatin, 0.6 M leupeptin, and 2 mM benzamidine. After disruption of the cells with a Bead-Beater (Biospec Products Inc., Bartlesville, Okla.), cell debris was removed by 10 min of centrifugation at 30,000 ϫ g, and then the homogenate was centrifuged for 90 min at 320,000 ϫ g. Solid ammonium sulfate (0.33 g/ml, nominally 55%) was added to the cleared supernatant to remove inhibitory deaminase and phosphatase activities (20) . The precipitate was dissolved and equilibrated in the same buffer as described above, the ammonium sulfate was removed by chromatography on a Sephadex G-25 column, and the eluate was frozen in aliquots at Ϫ70°C. Protein concentrations were determined by the Bradford method (2). The ribonucleotide reductase assay mixture contained, in a total volume of 0.12 ml, 40 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 2.5 mM ATP, 10 mM dithiothreitol, 20 M FeCl 3 , 0.5 mM H]cytidine diphosphate (specific activity, 37,000 cpm/nmol), 10 M E. coli thioredoxin, and the fractionated cell extract (0.3 to 0.4 mg of protein). After incubation at 30°C for 30 min, the conversion of CDP to dCDP was determined as described earlier (9) . Recombinant yeast Rnr1p and Rnr4p proteins were expressed in E. coli by using the pET expression system (31) and purified to homogeneity (2a) .
Nucleotide sequence accession number. The nucleotide sequence data reported in this paper appears in the GenBank nucleotide sequence database under accession number U30385.
RESULTS
Identification of a second ribonucleotide reductase small subunit in yeast. Thomas et al. (32) isolated six yeast mutants that are cold sensitive for growth and resistant to levels of the microtubule-depolymerizing drug benomyl that inhibit the growth of wild-type cells. Complementation tests suggested that all of these strains contain a mutation in the same gene. One of these mutations, tub2-104, was shown to be single-basepair change in the coding sequence of TUB2, which encodes ␤-tubulin, so all were referred to as tub2 mutations. We have now shown that one of these mutations, originally called tub2-158, is not an allele of TUB2, and we have renamed it rnr4-1 for reasons given below. In our hands, rnr4-1 does complement the cold sensitivity of eight independent cold-sensitive alleles of TUB2, including tub2-104. In addition, we have shown that rnr4-1 is not linked to the TUB2 locus. The rnr4-1 strain CUY58 was crossed to CUY848, which contains the URA3 gene integrated adjacent to the TUB2 locus. Following sporulation and tetrad dissection, the URA3 marker segregated independently from cold sensitivity (parental ditype/tetratype/ nonparental ditype ratio ϭ 2:10:1). Similar crosses to CUY111 and CUY117 showed that rnr4-1 is also unlinked to both the TUB1 and TUB3 genes, which encode the ␣-tubulins.
The wild-type RNR4 gene was cloned by complementation of the cold-sensitive phenotype of rnr4-1. A yeast genomic library was transformed into CUY58, and transformants were selected for growth at 14°C. One plasmid, pRC1, which con- tains a ϳ7 kb insert (Fig. 1) , was recovered. To determine the chromosomal origin of this insert, the BglII-BamHI fragment from pRC1 was used to probe a lambda phage library containing clones of yeast genomic DNA (25) . The probe hybridized to two overlapping clones (ATCC 70574 and 70647) which contain the QCR9 gene on chromosome VII. Restriction mapping and partial DNA sequencing demonstrated that the QCR9 gene is contained near one end of the insert in pRC1.
The rnr4-1 strain CUY58 was crossed to CUY977, which contains the URA3 gene integrated at the QCR9 locus. Sporulation and tetrad analysis indicated that rnr4-1 and QCR9 are tightly linked (parental ditype/tetratype/nonparental ditype ratio ϭ 26:3:0). This result confirms that the RNR4 gene, and not a dosage suppressor of rnr4-1, had been cloned. The region of pRC1 that complements the cold sensitivity of rnr4-1 was localized to a 2.4-kb BamHI-KpnI fragment at the end of the insert opposite QCR9 (Fig. 1) . Deletion of the ϳ850-bp internal SpeI fragment eliminates complementing activity, indicating that the RNR4 gene is at least partially contained within this region. We sequenced ϳ1,500 bp of DNA from ϳ150 bp upstream of the BglII site to ϳ200 bp upstream of the second SpeI site. This region was found to contain a single 1,035-bp open reading frame that potentially encodes a 345-amino-acid, 40-kDa protein. Our sequencing was subsequently confirmed by the yeast genome sequencing project.
Rnr4p is similar to the small subunits of class I ribonucleotide reductases from a variety of organisms (Table 2) . It is most similar to Rnr2p, the only other R2-like protein in S. cerevisiae. Rnr2p is a 399-amino-acid, 46-kDa protein that is essential for the viability of yeast (7, 14) . It contains a 51-amino-acid N-terminal peptide that is lacking in Rnr4p. Aside from this sequence, the two proteins are 54% identical. The alignment is shown in Fig. 2 and requires three single-aminoacid gaps in the Rnr4p sequence.
The 16 amino acid residues that are conserved in all R2 proteins identified to date are indicated in Fig. 2 . The radicalharboring tyrosine is at position 183 in Rnr2p. Rnr4p does possess a tyrosine residue in the equivalent position (amino acid 131) but contains substitutions at 6 of the remaining 15 conserved positions. Three of these substitutions affect amino acids that are directly involved in the coordination of the iron complex (17, 22) . These include the two histidine residues in Rnr2p (at positions 179 and 276), which are both tyrosine residues in Rnr4p (at positions 127 and 223), and the glutamate residue in Rnr2p (at position 273), which is an arginine residue in Rnr4p (at position 230).
Cold-sensitive phenotype of rnr4 mutants. To determine whether Rnr4p function is essential in yeast, we replaced the RNR4 sequence with a DNA fragment containing the HIS3 gene. The RNR4 sequence replaced extended from the BglII site located ϳ50 nucleotides upstream of the start codon (the nearest open reading frame upstream of RNR4 is ϳ2 kb away) to the EcoRI site located within the RNR4 sequence encoding amino acid 302. This construct was transformed into the diploid strain CUY546. Two transformants were sporulated, and tetrads were dissected. Most tetrads contained four viable spores, indicating that the RNR4 gene is not essential for the growth of yeast. However, cells containing the RNR4 disruption (rnr4-⌬1) grow slowly; the generation time of rnr4-⌬1 cells is about 50% greater than the generation time of RNR4 cells. Like the rnr4-1 mutant, rnr4-⌬1 cells are also cold sensitive and resistant to benomyl (see below).
Both rnr4-1 and rnr4-⌬1 cells fail to grow at 14°C and display a cell cycle arrest following a shift to this restrictive temperature. After 16 h at 14°C (about two generation times for RNR4 cells at this temperature), greater than 80% of the cells in rnr4-1 and rnr4-⌬1 cultures were large budded. Most of these large-budded cells (80% for rnr4-1 cells and 95% for rnr4-⌬1 cells) contained a single undivided nucleus and a short preanaphase spindle (Fig. 3) . Flow cytometry indicated that these cells are blocked prior to or in S phase (Fig. 4) . Because the rnr4-⌬1 mutation slows growth even at the permissive temperature, S-phase cells also accumulate at 30°C.
Drug sensitivity of the rnr4 mutants. Ribonucleotide reductase is inhibited by hydroxyurea, which specifically quenches the enzyme's tyrosyl radical (19) . We measured the sensitivity of cells to this drug by spotting suspensions of cells on plates containing various amounts of hydroxyurea. RNR4 cells are able to grow on plates containing up to 100 mM hydroxyurea at 30°C. rnr4-⌬1 cells are hypersensitive to hydroxyurea; they fail to grow on 25 mM hydroxyurea and grow only poorly on 10 mM hydroxyurea ( Table 3 ). The rnr4-1 mutant is also hypersensitive to hydroxyurea but less so than the deletion mutant; rnr4-1 cells fail to grow on 100 mM and grow poorly on 50 mM hydroxyurea. Cells containing a heat-sensitive mutation in the RNR2 gene (rnr2-68) are more sensitive to this drug than either of the rnr4 mutants; the rnr2-68 mutant fails to grow on 5 mM hydroxyurea, the lowest concentration tested. We could not test the drug sensitivity of cells lacking Rnr2p, because it is essential for growth.
The rnr4-⌬1 cells are more resistant to benomyl than RNR4 cells but not as resistant as rnr4-1 cells. rnr4-1 cells grow on plates containing 40 g of benomyl per ml at 30°C, nearly twice the level that inhibits the growth of RNR4 cells. rnr4-⌬1 cells grow on 30 g of benomyl per ml but not on 40 g/ml. The rnr2-68 mutation confers benomyl resistance similar to that produced by the rnr4-⌬1 mutation. We found that this effect could be mimicked by treating wild-type yeast strains with hydroxyurea. In the presence of 25 or 50 mM hydroxyurea, CUY8 and CUY26 cells could grow on plates that also contained 40 g of benomyl per ml. Thus, benomyl resistance appears to be a secondary consequence of inhibition of ribonucleotide reductase function. Perhaps limiting ribonucleotide reductase activity slows cell cycle progression during a phase that is critical for spindle formation, allowing cells more time to overcome the adverse effects of the drug on microtubule assembly.
Petite phenotype of rnr4 mutants. The original rnr4-1 mutant is a petite strain, a term used to describe yeast cells that lack mitochondrial function (11) . In an attempt to recover rnr4-1 grandes, we crossed the rnr4-1 mutant to an RNR4 grande strain, sporulated the resulting RNR4/rnr4-1 diploid, and dissected tetrads. The petite phenotype (assayed as inability to grow on YPG plates) segregated 2:2, indicating a single nuclear gene defect, and cosegregated with cold sensitivity and benomyl resistance, indicating that the petite phenotype is due to the rnr4-1 mutation. Thus, the rnr4-1 cells become petite at a high rate. We observed the same result for rnr4-⌬1 spores when RNR4/rnr4-⌬1 diploids were sporulated and dissected.
We next tested whether the petite phenotype was a direct effect of the rnr4-1 mutation or was a secondary effect of the mutation on the maintenance of a functional mitochondrial genome. The rnr4-1 petite strain (CUY59) was crossed to an RNR4 grande strain (DL2). This diploid is able to grow on YPG plates, indicating that the rnr4-1 mutation is recessive for the petite phenotype. The rnr4-1 petite strain (CUY59) was also crossed to an RNR4 rho 0 strain (DL2rho 0 ) which lacks all mitochondrial DNA. The diploid product of this cross did not grow on YPG plates, indicating that the rnr4-1 haploid parent does not contain functional mitochondria. This result suggests that Rnr4p is required for proper maintenance of the mitochondrial genome.
Ribonucleotide reductase activity in rnr4 mutant extracts. Wild-type yeast extract contains low levels of ribonucleotide reductase activity (Table 4) . However, addition of bacterially expressed Rnr1p greatly stimulated this activity, indicating that the Rnr1p subunit is limiting in yeast extracts. Addition of bacterially expressed Rnr4p had little effect on the activity of wild-type extracts in either the absence or presence of added Rnr1p. Bacterially expressed Rnr1p and Rnr4p alone or in combination did not produce any detectable activity in the absence of yeast extract.
Ribonucleotide reductase activity was not detectable in rnr4-⌬1 extracts. Addition of Rnr4p increased activity to the low level observed for wild-type extracts without addition of exogenous protein. With the addition of Rnr1p alone to the mutant extracts, ribonucleotide reductase levels increased but were four to five times lower than that of wild-type extracts with added Rnr1p. However, addition of Rnr4p and Rnr1p to the rnr4-⌬1 extracts brought the ribonucleotide reductase levels up to that observed for wild-type extracts under the same conditions. Thus, the rnr4-⌬1 mutant is deficient in ribonucleotide reductase activity, and this deficiency can be remedied by the addition of exogenous Rnr4p.
Induction of RNR4 by hydroxyurea and MMS.
Previous work has shown that the RNR2 gene is induced by DNAdamaging agents (7, 13) . We found that the DNA-damaging agent MMS strongly induces RNR4 as well. RNA was prepared from yeast cells at 0, 1, and 2 h after exposure to MMS. Northern blot analysis showed that the RNR4 transcript increased approximately 10-fold following treatment with MMS (Fig. 5) . Treatment with hydroxyurea produced a similar level of RNR4 induction (Fig. 5) .
Rnr4p and Rnr2p are not functionally redundant. Because both RNR2 and RNR4 encode ribonucleotide reductase small subunits, we examined whether multiple copies of either one of these genes could compensate for mutations in the other gene. A wild-type copy of each gene on a high-copy-number 2m YEp plasmid was transformed into RNR4, rnr4-1, rnr4-⌬1, and rnr2-68 strains. These strains were scored for growth over a range of temperatures and on a range of concentrations of hydroxyurea (Table 3) .
Neither gene on a high-copy-number plasmid has any effect on the temperature sensitivity or drug sensitivity of RNR4 cells. The plasmid-borne RNR4 gene complements the cold and hydroxyurea sensitivity conferred by both the rnr4-1 and the rnr4-⌬1 mutations. (RNR4 on a YCp plasmid also complements these phenotypes.) Similarly, the plasmid-borne RNR2 gene complements the heat and hydroxyurea sensitivity of the rnr2-68 mutation. In contrast, the plasmid-borne RNR2 gene does not complement the cold or hydroxyurea sensitivity caused by either rnr4 mutation. In fact, high-copy RNR2 increases the hydroxyurea sensitivity of the rnr4-⌬1 strain and causes it to be slightly heat sensitive. Similarly, high-copy RNR4 does not complement the heat or hydroxyurea sensitivity caused by the rnr2-68 mutation but does make the rnr2-68 strain somewhat cold sensitive. Mutation of Tyr131 does not affect Rnr4p function. Although Rnr4p is quite similar to Rnr2p in overall sequence, it lacks a number of amino acid residues thought to be essential for coordination of the iron complex, which in turn is essential for generating the tyrosyl radical. This suggests that the cellular function of Rnr4p may not require the tyrosyl radical. To test this possibility, we changed the tyrosine at position 131 in Rnr4p to phenylalanine. Phenylalanine lacks the aromatic hydroxyl group of tyrosine and cannot form a radical. Otherwise, phenylalanine and tyrosine are identical, so this change will have a minimal effect on the structure of Rnr4p. The allele of RNR4 containing the Tyr131Phe substitution is called rnr4-2.
The RNR4 gene and the rnr4-2 allele on yeast centromerecontaining plasmids were transformed into rnr4-1 and rnr4-⌬1 yeast cells. Transformants were scored for their ability to grow in the cold and on 100 mM hydroxyurea. As shown in Fig. 6 , the plasmid-borne copy of rnr4-2 complements the cold sensitivity and hydroxyurea hypersensitivity of both the rnr4-1 and rnr4-⌬1 alleles. This result indicates that the cellular function of Rnr4p does not depend on its ability to form the tyrosyl radical.
DISCUSSION
We have identified a second S. cerevisiae protein with similarity to the small subunit of ribonucleotide reductase. Rnr4p is 54% identical to Rnr2p, 40 to 50% identical to R2 proteins from a number of other eukaryotic organisms, and distantly related to the E. coli R2 protein. Rnr4p does lack the Nterminal 51 amino acids of Rnr2p, but it is unlikely that this N terminus is needed for the enzymatic activity of Rnr2p. These N-terminal residues are absent from R2 proteins in many species, and truncation of N-terminal residues in mouse R2 does not significantly affect its enzymatic activity (21) .
The phenotypes of the rnr4 mutants are consistent with the idea that Rnr4p plays a role in ribonucleotide reductase function. rnr4 mutants are hypersensitive to hydroxyurea, a drug that specifically inhibits ribonucleotide reductase. Yeast cells lacking RNR4 grow slowly at optimal growth temperatures and fail to grow in the cold. At the restrictive temperature, rnr4 mutants display an S-phase arrest similar to that observed following treatment of RNR4 cells with hydroxyurea (8) . rnr4 mutants also lose mitochondrial function at a high rate, a phenotype previously observed for an rnr2 mutant (7). A likely explanation for this latter phenotype is that the rnr mutations impede mitochondrial DNA replication by limiting the pools of deoxyribonucleotide precursors.
To determine directly whether Rnr4p plays a role in ribonucleotide reductase activity, we assayed this activity in extracts from wild-type cells and cells lacking Rnr4p. Wild-type extracts contain only low levels of activity, which are greatly stimulated by the addition of exogenous Rnr1p. The finding that Rnr1p is limiting in yeast extracts is consistent with the previous suggestion that the cell cycle regulation of ribonucleotide reductase activity is likely to be due primarily to fluctuation in the levels of RNR1 message (8) . The observation that RNR4 deletion mutations can be suppressed by overexpression of RNR1 also indicates that Rnr1p is limiting in vivo (12) .
Cells lacking Rnr4p are deficient in ribonucleotide reductase activity. Extracts from rnr4-⌬1 cells contain four-to fivefoldlower levels of this activity than wild-type cell extracts. The addition of exogenous Rnr4p to the mutant extracts increases their activity to wild-type levels. This result demonstrates that the reduction in ribonucleotide reductase levels in the mutant cells is a direct effect of the loss of Rnr4p.
The regulation of expression of RNR4 is consistent with that expected for a gene encoding a subunit of ribonucleotide reductase. We found that the DNA-damaging agent and mutagen MMS strongly induces expression of the RNR4 gene. RNR4 thus shares with RNR1, RNR2, and RNR3 the ability to be induced by agents that damage DNA (7, 8, 13) .
The fact that Rnr2p and Rnr4p are similar in sequence suggests that they could be redundant in function. If this were the case, the phenotype associated with the loss of either gene could be due to an overall decrease in the levels of ribonucleotide reductase. The more severe phenotype associated with the loss of Rnr2p could be explained by hypothesizing that the RNR2 gene produces more protein product than RNR4. However, neither gene on a high-copy-number plasmid can compensate for a mutation in the other gene. Thus, Rnr2p and Rnr4p do not perform equivalent functions in the cell. This result differs from that observed for the two yeast R1 proteins, Rnr1p and Rnr3p. The RNR1 gene is essential for viability, but the RNR3 gene is not. However, RNR3 on a high-copy-number plasmid can suppress the lethality of rnr1 mutations (8) .
Although Rnr4p is clearly similar to ribonucleotide reductase small-subunit proteins from a variety of eukaryotic cells, it lacks a number of amino acid residues that are conserved in all other R2 proteins. Many of these residues are thought to be essential for coordination of the binuclear iron complex, which in turn is required for generation of the tyrosyl radical. The X-ray structure of E. coli R2 indicates that each iron atom is octahedrally coordinated by a histidine N␦ atom and five O atoms (22) . These coordinating atoms are derived from six amino acid residues located at the iron-binding site and an O 2Ϫ ion. Five of these amino acids are conserved in all R2 proteins identified until now; the other is an aspartate residue in all R2 proteins except the Epstein-Barr virus protein, which contains a glutamate residue at this site. Rnr4p has substitutions at three of these six positions. In particular, Rnr4p lacks the two histidine residues that bind to the iron atoms with their ␦-nitrogen atoms. Both of these sites contain tyrosine residues in Rnr4p. The chemical and physical properties of tyrosine make it unlikely that this amino acid can substitute for histidine in the coordination of the iron complex. In addition, one of the glutamate residues that binds the iron complex via its carboxyl group is changed to an arginine residue in Rnr4p. Again, the obvious differences in the chemical properties of these two amino acids make it extremely unlikely that arginine could functionally replace glutamate in iron coordination. Thus, it would appear that these three amino acid substitutions preclude iron binding and, hence, tyrosyl radical formation by Rnr4p.
To determine more specifically whether tyrosyl radical formation plays a role in Rnr4p function, we changed the activesite tyrosine residue to phenylalanine. Phenylalanine lacks the aromatic hydroxyl group of tyrosine and therefore cannot form a radical. This tyrosine-to-phenylalanine mutation has no effect on the function of Rnr4p that we can observe. The mutant allele, rnr4-2, fully complements the cold sensitivity and hydroxyurea hypersensitivity of both the rnr4-1 mutation and the rnr4-⌬1 deletion.
The fact that the cellular function of Rnr4p does not require formation of a tyrosyl radical leads us to propose that this protein is enzymatically inactive. Nonetheless, the phenotypes of the rnr4 mutants indicate that it does play an important role in ribonucleotide reductase function. One possibility is that Rnr4p acts as an antagonist to Rnr2p to modulate the level of reductase activity. In this role, Rnr4p could have a negative effect on reductase activity by forming enzymatically inactive complexes with Rnr1p or Rnr3p and effectively lowering the levels of these proteins in the cell. However, cells lacking Rnr4p have lower levels of ribonucleotide reductase activity, ruling out a negative role for Rnr4p. Alternatively, Rnr4p could have a positive effect on reductase activity by binding to and titrating out a negative regulator of Rnr2p. If Rnr4p functions in this manner, then one would predict that the relative levels of Rnr2p and Rnr4p would be critical. However, increasing the copy number of either RNR2 or RNR4 produced no observable phenotype in wild-type cells.
Therefore, we currently favor the hypothesis that Rnr4p is a nonenzymatic component of the active ribonucleotide reductase complex. We propose that the primary R2 complex in yeast is a heterodimer composed of Rnr2p and Rnr4p. Catalytic activity resides only in the Rnr2p subunit, but Rnr4p is an important structural component of the active tetramer. In support of this model, Huang and Elledge (12) have shown that Rnr2p and Rnr4p interact in vivo.
Such a situation is not unprecedented. In the bacterial photosynthetic reaction center, chromophoric groups are arranged with nearly perfect twofold symmetry (5). This symmetry arises because the L and M subunits, with which these groups are associated, have homologous sequences and similar structures. However, the two symmetry-related groups of chromophores are not functionally equivalent; electrons are almost exclusively transferred through the L subunit. This effect is attributed to subtle differences between the L and M subunits. A second pertinent example is reverse transcriptase, a dimeric protein of p66 and p51 (16, 18) . Both subunits are initially synthesized as identical 66-kDa polypeptides. However, the RNase H domain of one of the two subunits is proteolytically excised, yielding a 51-kDa polypeptide. Although the polymerase domains of p66 and p51 are chemically identical, only the polymerase domain of p66 is active. Thus, reverse transcriptase is composed of two nearly identical polypeptides, but only one of these plays a catalytic role. Clearly, structural studies on the yeast ribonucleotide reductase will have to be performed before we can determine the relevance of these examples to Rnr2p and Rnr4p.
